Viking Therapeutics (VKTX) Shares Outstanding (Entity) (2014 - 2026)
Viking Therapeutics (VKTX) posted Shares Outstanding (Entity) of 116.65 million for Q2 2026, up 3.8% from 112.33 million a year earlier and up 0.7% from the prior quarter.
Powered by 
Analysis
Viking Therapeutics (VKTX) Shares Outstanding (Entity) (2014 - 2026) Analysis & Trends
For FY2025, Viking Therapeutics' Shares Outstanding (Entity) came in at 114.79 million, up 2.9% from FY2024.
- Annual Shares Outstanding (Entity) has increased for three consecutive years, with a five-year compound annual growth rate of 9.4% (FY2020 to FY2025).
- In prior years, Viking Therapeutics' Shares Outstanding (Entity) was 111.57 million in FY2024 (+11.4%), 100.11 million in FY2023 (+27.9%), 78.26 million in FY2022 (unchanged) and 78.25 million in FY2021 (+6.9%).
- The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2014.
- On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last 14 quarters, with growth averaging 4.6% over the last eight quarters.
- The strongest year-over-year quarter for Shares Outstanding (Entity) in the past five years was Q1 2024, with growth of 39.0%; the weakest was Q3 2022, with a decline of 2.0%.
- According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 115.89 million (Q1 2026), 114.79 million (Q4 2025) and 112.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Viking Therapeutics | 3.07 Bn | 545.20 Mn | - | 116.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 116.65 Mn |
| Mar 31, 2026 | 115.89 Mn |
| Dec 31, 2025 | 114.79 Mn |
| Sep 30, 2025 | 112.45 Mn |
| Jun 30, 2025 | 112.33 Mn |
| Mar 31, 2025 | 112.29 Mn |
| Dec 31, 2024 | 111.57 Mn |
| Sep 30, 2024 | 111.43 Mn |
| Jun 30, 2024 | 110.80 Mn |
| Mar 31, 2024 | 110.23 Mn |
| Dec 31, 2023 | 100.11 Mn |
| Sep 30, 2023 | 100.03 Mn |
| Jun 30, 2023 | 100.03 Mn |
| Mar 31, 2023 | 79.32 Mn |
| Dec 31, 2022 | 78.26 Mn |
| Sep 30, 2022 | 76.69 Mn |
| Jun 30, 2022 | 76.69 Mn |
| Mar 31, 2022 | 77.37 Mn |
| Dec 31, 2021 | 78.25 Mn |
| Sep 30, 2021 | 78.23 Mn |
API Access
Viking Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();